Literature DB >> 32116448

Overview of Therapeutic Inertia in Diabetes: Prevalence, Causes, and Consequences.

Susan L Karam1, Jared Dendy1, Shruti Polu1, Lawrence Blonde1.   

Abstract

Many people with diabetes do not achieve individualized treatment targets. Therapeutic inertia, the underuse of effective therapies in preventing serious clinical end points, is a frequent, important contributor to this failure. Clinicians, patients, health systems, payors, and producers of medications, devices, and other products for those with diabetes all play a role in the development of therapeutic inertia and can all help to reduce it.
© 2020 by the American Diabetes Association.

Entities:  

Year:  2020        PMID： 32116448      PMCID： PMC7026754          DOI： 10.2337/ds19-0029

Source DB:  PubMed          Journal:  Diabetes Spectr        ISSN： 1040-9165


  65 in total

Review 1.  Clinical inertia.

Authors:  L S Phillips; W T Branch; C B Cook; J P Doyle; I M El-Kebbi; D L Gallina; C D Miller; D C Ziemer; C S Barnes
Journal:  Ann Intern Med       Date:  2001-11-06       Impact factor: 25.391

2.  CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2019 EXECUTIVE SUMMARY.

Authors:  Alan J Garber; Martin J Abrahamson; Joshua I Barzilay; Lawrence Blonde; Zachary T Bloomgarden; Michael A Bush; Samuel Dagogo-Jack; Ralph A DeFronzo; Daniel Einhorn; Vivian A Fonseca; Jeffrey R Garber; W Timothy Garvey; George Grunberger; Yehuda Handelsman; Irl B Hirsch; Paul S Jellinger; Janet B McGill; Jeffrey I Mechanick; Paul D Rosenblit; Guillermo E Umpierrez
Journal:  Endocr Pract       Date:  2019-01       Impact factor: 3.443

3.  A1C Targets Should Be Personalized to Maximize Benefits While Limiting Risks.

Authors:  Matthew C Riddle; Hertzel C Gerstein; Rury R Holman; Silvio E Inzucchi; Bernard Zinman; Sophia Zoungas; William T Cefalu
Journal:  Diabetes Care       Date:  2018-06       Impact factor: 19.112

4.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

Authors:  D M Nathan; S Genuth; J Lachin; P Cleary; O Crofford; M Davis; L Rand; C Siebert
Journal:  N Engl J Med       Date:  1993-09-30       Impact factor: 91.245

5.  Transition to insulin in Type 2 diabetes: family physicians' misconception of patients' fears contributes to existing barriers.

Authors:  Sasson Nakar; Gila Yitzhaki; Reena Rosenberg; Shlomo Vinker
Journal:  J Diabetes Complications       Date:  2007 Jul-Aug       Impact factor: 2.852

6.  Endothelium, inflammation, and diabetes.

Authors:  Ahmad Aljada
Journal:  Metab Syndr Relat Disord       Date:  2003-03       Impact factor: 1.894

7.  Prevalence of Total, Diagnosed, and Undiagnosed Diabetes Among Adults: United States, 2013-2016.

Authors:  Nicholas D Mendola; Te-Ching Chen; Qiuping Gu; Mark S Eberhardt; Sharon Saydah
Journal:  NCHS Data Brief       Date:  2018-09

8.  Competing demands or clinical inertia: the case of elevated glycosylated hemoglobin.

Authors:  Michael L Parchman; Jacqueline A Pugh; Raquel L Romero; Krista W Bowers
Journal:  Ann Fam Med       Date:  2007 May-Jun       Impact factor: 5.166

9.  Diabetic patients' medication underuse, illness outcomes, and beliefs about antihyperglycemic and antihypertensive treatments.

Authors:  James E Aikens; John D Piette
Journal:  Diabetes Care       Date:  2008-10-13       Impact factor: 17.152

10.  The Legacy Effect in Type 2 Diabetes: Impact of Early Glycemic Control on Future Complications (The Diabetes & Aging Study).

Authors:  Neda Laiteerapong; Sandra A Ham; Yue Gao; Howard H Moffet; Jennifer Y Liu; Elbert S Huang; Andrew J Karter
Journal:  Diabetes Care       Date:  2018-08-13       Impact factor: 17.152
View more
  4 in total

Review 1.  Quality of Diabetes Care in the USA.

Authors:  Ben Alencherry; Dennis Bruemmer
Journal:  Curr Cardiol Rep       Date:  2021-06-03       Impact factor: 2.931

2.  CRS Diabetes: An Effective Model for Improving Family Medicine Resident Knowledge, Competence, and Performance in Diabetes Care.

Authors:  Nora A Williams; Stephen A Brunton; Gregory A Scott
Journal:  Clin Diabetes       Date:  2022-01

3.  The effectiveness and safety of recombinant human growth hormone combined with alginate dressing in the treatment of diabetic foot ulcer: A protocol for systematic review and meta-analysis.

Authors:  Deng-Rong Zhou; Hai-Yan Deng; Lin-Li Pu; Shao-Lan Lin; Rong Gou; Feng-Ling Wang
Journal:  Medicine (Baltimore)       Date:  2021-02-05       Impact factor: 1.817

4.  Factors Associated with Adherence to Clinical Practice Guidelines for Patients with Type 2 Diabetes Mellitus: Results of a Spanish Delphi Consensus.

Authors:  José Antonio Gimeno; Gloria Cánovas; Alejandra Durán
Journal:  J Diabetes Res       Date:  2021-10-23       Impact factor: 4.011
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.